Endeavour of govt is to provide affordable quality healthcare for all: Gowda

New Delhi: The government Thursday said it endeavours to provide affordable quality healthcare for all while also working to boost the domestic pharmaceutical sector through ‘Make in India’. As part of its efforts to give an impetus to the sector, Union Minister for Chemicals and Fertilisers D V Sadananda Gowda will meet leaders of pharmaceutical and medical devices industry to discuss policy and challenges facing the industry, during the international conference being organised in Bengaluru in February.

“The endeavour of the government is to provide affordable quality healthcare for all and boost indigenous pharma sector through ‘Make in India’,” Gowda said while addressing media during a curtain raiser for ‘India Pharma 2019 & India Medical Device 2019’ here.

The minister further said to boost the sector, the Cabinet has already given approval for 100 per cent FDI under automatic route for manufacturing of medical devices.

The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, along with the Federation of Indian Chambers of Commerce and Industry, is organising the 4th International Conference on Pharmaceutical & Medical Devices sector on February 18 and 19 in Bengaluru.

Seeking to address concerns of the industry over various issues, including price control, the minister said the event would provide an opportunity to discuss government policy and challenges facing the industry.

“The government is striving to make the processes in the sector as transparent and easy as possible,” he added.

The flagship event would bring key stakeholders of the pharma and medical devices sectors under one roof, Gowda said.

The theme for India Pharma 2019 is ‘Enabling Quality Affordable Healthcare’ and that of India Medical Device 2019 is ‘Med-Tech India: Gearing up for Ayushman Bharat’.
NewsletterA A

  • Related Posts

    TG SAFE drug wing raids medical shop in Sangareddy, seizes illegal tramadol worth Rs. 58,904

    In a swift enforcement action against the unauthorized distribution of habit-forming medications, officials from the Drug Control Wing under the Telangana Standards Authority for Food and Essential Drugs (TG SAFE)…

    FDA cancels wholesale drug sales license of Cipla Pharma & Life sciences Ltd

    According to the FDA commissioner, the aim of the FDA is not merely to take regulatory action, but to ensure the safety and quality of medicines and statutory compliance throughout…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    TG SAFE drug wing raids medical shop in Sangareddy, seizes illegal tramadol worth Rs. 58,904

    TG SAFE drug wing raids medical shop in Sangareddy, seizes illegal tramadol worth Rs. 58,904

    FDA cancels wholesale drug sales license of Cipla Pharma & Life sciences Ltd

    FDA cancels wholesale drug sales license of Cipla Pharma & Life sciences Ltd

    At least five workers killed in boiler explosion at pharma unit in Andhra Pradesh’s Sri City SEZ

    At least five workers killed in boiler explosion at pharma unit in Andhra Pradesh’s Sri City SEZ

    Unauthorised Pakistani cosmetics worth ₹7 lakh seized from Hyderabad’s Nampally and Habeeb Nagar stores

    Unauthorised Pakistani cosmetics worth ₹7 lakh seized from Hyderabad’s Nampally and Habeeb Nagar stores

    FSSAI suspends licence of Delhi-based hospitality establishment for ‘serious non-compliance’

    FSSAI suspends licence of Delhi-based hospitality establishment for ‘serious non-compliance’

    Meet Samrat of Robotic Surgery, poised to bring Dawn of Cutting-edge Healthcare in Bihar

    Meet Samrat of Robotic Surgery, poised to bring Dawn of Cutting-edge Healthcare in Bihar